Suppr超能文献

肿瘤坏死因子-α转化酶(TACE)受到金属蛋白酶组织抑制因子-3(TIMP-3)的抑制。

TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.

作者信息

Amour A, Slocombe P M, Webster A, Butler M, Knight C G, Smith B J, Stephens P E, Shelley C, Hutton M, Knäuper V, Docherty A J, Murphy G

机构信息

School of Biological Sciences, University of East Anglia, Norwich, UK.

出版信息

FEBS Lett. 1998 Sep 11;435(1):39-44. doi: 10.1016/s0014-5793(98)01031-x.

Abstract

TNF-alpha converting enzyme (TACE; ADAM-17) is a membrane-bound disintegrin metalloproteinase that processes the membrane-associated cytokine proTNF-alpha to a soluble form. Because of its putative involvement in inflammatory diseases, TACE represents a significant target for the design of specific synthetic inhibitors as therapeutic agents. In order to study its inhibition by tissue inhibitors of metalloproteinases (TIMPs) and synthetic inhibitors of metalloproteinases, the catalytic domain of mouse TACE (rTACE) was overexpressed as a soluble Ig fusion protein from NS0 cells. rTACE was found to be well inhibited by peptide hydroxamate inhibitors as well as by TIMP-3 but not by TIMP-1, -2 and -4. These results suggest that TIMP-3, unlike the other TIMPs, may be important in the modulation of pathological events in which TNF-alpha secretion is involved.

摘要

肿瘤坏死因子-α转化酶(TACE;ADAM-17)是一种膜结合的解聚素金属蛋白酶,它将膜相关细胞因子前肿瘤坏死因子-α加工成可溶性形式。由于其可能参与炎症性疾病,TACE是设计作为治疗剂的特异性合成抑制剂的重要靶点。为了研究金属蛋白酶组织抑制剂(TIMPs)和金属蛋白酶合成抑制剂对其的抑制作用,从小鼠TACE(rTACE)的催化结构域作为来自NS0细胞的可溶性Ig融合蛋白进行了过表达。发现rTACE受到肽羟基肟酸抑制剂以及TIMP-3的良好抑制,但不受TIMP-1、-2和-4的抑制。这些结果表明,与其他TIMPs不同,TIMP-3可能在调节涉及肿瘤坏死因子-α分泌的病理事件中起重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验